As of April 15, 2025, Medpace (MEDP) has a market cap of $9.22 billion USD. According to our data, Medpace is ranked No.1725 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $9.22 B |
-10.72%
|
Dec 31, 2024 | $10.33 B |
8.38%
|
Dec 29, 2023 | $9.53 B |
44.31%
|
Dec 30, 2022 | $6.60 B |
-2.40%
|
Dec 31, 2021 | $6.76 B |
56.35%
|
Dec 31, 2020 | $4.33 B |
65.60%
|
Dec 31, 2019 | $2.61 B |
58.81%
|
Dec 31, 2018 | $1.65 B |
45.97%
|
Dec 29, 2017 | $1.13 B |
0.53%
|
Dec 30, 2016 | $1.12 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() IQVIA
IQV
|
$26.30 B |
0.001 M
|
![]() USA
|
![]() ICON plc
ICLR
|
$11.73 B |
0.000 M
|
![]() Ireland
|
![]() Charles River Laboratories
CRL
|
$5.20 B |
-0.000 M
|
![]() USA
|
![]() LabCorp
LH
|
$18.91 B |
0.000 M
|
![]() USA
|
![]() Medpace
MEDP
|
$9.22 B |
-0.000 M
|
![]() USA
|
![]() HeartBeam
BEAT
|
$55.65 M |
0.000 M
|
![]() USA
|
Market Cap | = | MEDP Stock Price | * | MEDP Shares Outstanding |
= | $305.00 | * | 30.23 M | |
= | $9.22 B |